Markogenin is used in the pharmaceutical industry as an intermediate in the synthesis of steroidal drugs. It plays a role in the development of anti-inflammatory, hormonal, and contraceptive medications due to its structural similarity to natural steroid hormones. Its derivatization allows for the production of compounds with targeted biological activity, particularly in modulating immune response and hormonal balance. Additionally, markogenin-based compounds are studied for potential anticancer properties, especially in hormone-related cancers such as breast and prostate cancer. It is also utilized in research settings to explore new bioactive molecules and structure-activity relationships in steroid chemistry.